Moving a cell culture process from the lab bench to a suspension bioreactor is often one of the first steps in commercialization of a cell and gene therapy product. This step, and any future scale-up work, requires specialized expertise and equipment.
This slide deck features the newest data from CCRM and GE Healthcare on the development of bioreactor-based culture protocols for pluripotent stem cells. Learn about the following topics in this slide deck:
- Scale-up considerations for Stirred-Tank Reactors (STRs)
- Cell line equivalence and Process Robustness
- Development of In-Process Controls
- Downstream Processing and Therapeutic Relevance
If you’re looking for information that will help you understand the steps requires to move your process into a bioreactor, this slide deck will be a fantastic resource.
